RHAG and neoplasm: Rh2 liposomes studied by Hong et al. [17] were used to prolong circulation in the bloodstream, but the clinical efficacy of liposomes is still limited by the complexity of the tumor microenvironment and the insufficient accumulation at the tumor site.